The anti-GPL-core antibody titer was not a good prognostic predictor because it showed no significant difference between patients with NC-NB lesions and those with FC lesions, although it may reflect disease activity, as in previous studies (24). This evidence concerns the gene IL31RA and neuroblastoma.